News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
SVLSF IV, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2021 |
SC 13D/A
| SVLSF IV, LLC reports a 0% stake in KALVISTA PHARMACEUTICALS, INC. |
| 11/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/15/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/10/2019 |
4
| SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 22,171 shares
@ $29.4919, valued at
$653.9k
Sold 629 shares
@ $29.4919, valued at
$18.6k
Sold 13,292 shares
@ $28.5305, valued at
$379.2k
Sold 377 shares
@ $28.5305, valued at
$10.8k
Sold 13,157 shares
@ $29.3952, valued at
$386.8k
Sold 374 shares
@ $29.3952, valued at
$11k
|
|
| 04/03/2019 |
SC 13D/A
| SVLSF IV, LLC reports a 10.3% stake in KALVISTA PHARMACEUTICALS, INC. |
| 04/02/2019 |
4
| SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 34,133 shares
@ $28.396, valued at
$969.2k
Sold 969 shares
@ $28.396, valued at
$27.5k
Sold 51,373 shares
@ $27.6582, valued at
$1.4M
Sold 1,458 shares
@ $27.6582, valued at
$40.3k
Sold 8,888 shares
@ $28.7638, valued at
$255.7k
Sold 253 shares
@ $28.7638, valued at
$7.3k
|
|
| 03/28/2019 |
4
| SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 29,262 shares
@ $29.6975, valued at
$869k
Sold 831 shares
@ $29.6975, valued at
$24.7k
Sold 56,318 shares
@ $29.0592, valued at
$1.6M
Sold 1,599 shares
@ $29.0592, valued at
$46.5k
Sold 35,653 shares
@ $27.801, valued at
$991.2k
Sold 1,012 shares
@ $27.801, valued at
$28.1k
|
|
| 03/20/2019 |
SC 13D/A
| SVLSF IV, LLC reports a 11.5% stake in KALVISTA PHARMACEUTICALS, INC. |
| 03/20/2019 |
4
| SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 255,224 shares
@ $26.7, valued at
$6.8M
Sold 7,246 shares
@ $26.7, valued at
$193.5k
|
|
| 03/06/2019 |
4
| SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 42,181 shares
@ $22.907, valued at
$966.2k
Sold 1,197 shares
@ $22.907, valued at
$27.4k
Sold 31,439 shares
@ $23.0365, valued at
$724.2k
Sold 893 shares
@ $23.0365, valued at
$20.6k
|
|
| 02/26/2019 |
SC 13D/A
| SVLSF IV, LLC reports a 13.5% stake in KALVISTA PHARMACEUTICALS, INC. |
| 02/21/2019 |
4
| SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 17,912 shares
@ $20.7328, valued at
$371.4k
Sold 508 shares
@ $20.7328, valued at
$10.5k
Sold 22,594 shares
@ $20.0159, valued at
$452.2k
Sold 641 shares
@ $20.0159, valued at
$12.8k
Sold 167,779 shares
@ $20.6, valued at
$3.5M
Sold 4,764 shares
@ $20.6, valued at
$98.1k
|
|
| 02/14/2019 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/07/2019 |
4
| SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 1,653 shares
@ $20.013, valued at
$33.1k
Sold 47 shares
@ $20.013, valued at
$940.6
Sold 2,527 shares
@ $20.412, valued at
$51.6k
Sold 72 shares
@ $20.412, valued at
$1.5k
|
|
| 01/02/2019 |
4
| SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 3,631 shares
@ $20.027, valued at
$72.7k
Sold 103 shares
@ $20.027, valued at
$2.1k
Sold 24,716 shares
@ $20.004, valued at
$494.4k
Sold 702 shares
@ $20.004, valued at
$14k
Sold 194 shares
@ $20, valued at
$3.9k
Sold 6 shares
@ $20, valued at
$120 |
|
| 12/21/2018 |
4
| SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 2,077 shares
@ $20.018, valued at
$41.6k
Sold 59 shares
@ $20.018, valued at
$1.2k
|
|
| 11/14/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/06/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/15/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 03/02/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 12/29/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/11/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/14/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/10/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/01/2017 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice |
| 03/02/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/07/2017 |
SC 13G/A
| SVLSF IV, LLC reports a 6.6% stake in TransEnterix, Inc. |
| 02/07/2017 |
SC 13G/A
| Lombard Medical, Inc. reports a 4.6% stake in LOMBARD MEDICAL, INC. |
|
|
|